THE MIZEUR GROUP, LLC

Lobbying for CLENE NANOMEDICINE · Biopharmaceutical company treating neurodegenerative diseases.

Filing 1st Quarter - Report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted May 20, 2025

Income

$5,000.00

What the client paid this registrant for the period.

Client based in

Maryland

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 1

Health Issues

Ongoing discussions about regulatory flexibility for accelerated approval of rare disease drugs for neurodegenerative conditions.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.